Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 1040K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Li, S. Articles by Darling, T. N. Search for Related Content PubMed PubMed Citation Articles by Li, S. Articles by Darling, T. N. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Medline Plus Health Information Tuberous Sclerosis Social Bookmarking                            What's this?

¹ Department of Dermatology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814
² Pulmonary-Critical Care Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892

CORRESPONDENCE Thomas N. Darling: tdarling{at}usuhs.mil

Patients with tuberous sclerosis complex (TSC) develop hamartomatous tumors showing loss of function of the tumor suppressor TSC1 (hamartin) or TSC2 (tuberin) and increased angiogenesis, fibrosis, and abundant mononuclear phagocytes. To identify soluble factors with potential roles in TSC tumorigenesis, we screened TSC skin tumor–derived cells for altered gene and protein expression. Fibroblast-like cells from 10 angiofibromas and five periungual fibromas produced higher levels of monocyte chemoattractant protein-1 (MCP-1) mRNA and protein than did fibroblasts from the same patient's normal skin. Conditioned medium from angiofibroma cells stimulated chemotaxis of a human monocytic cell line to a greater extent than conditioned medium from TSC fibroblasts, an effect blocked by neutralizing MCP-1–specific antibody. Overexpression of MCP-1 seems to be caused by loss of tuberin function because Eker rat embryonic fibroblasts null for Tsc2 (EEF Tsc2^–/–) produced 28 times as much MCP-1 protein as did EEF Tsc2^+/+ cells; transient expression of WT but not mutant human TSC2 by EEF Tsc2^–/– cells inhibited MCP-1 production; and pharmacological inhibition of the Rheb-mTOR pathway, which is hyperactivated after loss of TSC2, decreased MCP-1 production by EEF Tsc2^–/– cells. Together these findings suggest that MCP-1 is an important paracrine factor for TSC tumorigenesis and may be a new therapeutic target.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Pacheco-Rodriguez, G., Kumaki, F., Steagall, W. K., Zhang, Y., Ikeda, Y., Lin, J.-P., Billings, E. M., Moss, J. (2009). Chemokine-Enhanced Chemotaxis of Lymphangioleiomyomatosis Cells with Mutations in the Tumor Suppressor TSC2 Gene. J. Immunol. 182: 1270-1277 [Abstract] [Full Text]  
• Capoccia, B. J., Gregory, A. D., Link, D. C. (2008). Recruitment of the inflammatory subset of monocytes to sites of ischemia induces angiogenesis in a monocyte chemoattractant protein-1-dependent fashion. J. Leukoc. Biol. 84: 760-768 [Abstract] [Full Text]  
• Li, S., Takeuchi, F., Wang, J.-a., Fan, Q., Komurasaki, T., Billings, E. M., Pacheco-Rodriguez, G., Moss, J., Darling, T. N. (2008). Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas. Proc. Natl. Acad. Sci. USA 105: 3539-3544 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS